Experienced in Mononucleosis

Ka-on F. Lam

1/F Professorial Block, 102 Pokfulam Road, 
Hong Kong, HCW, HK 
Experienced in Mononucleosis
1/F Professorial Block, 102 Pokfulam Road, 
Hong Kong, HCW, HK 
OverviewLocationsClinical Research

Overview

Ka-on Lam practices in Hong Kong, Hong Kong Special Administrative Region. Mr. Lam is rated as an Experienced expert by MediFind in the treatment of Mononucleosis. His top areas of expertise are Nasopharyngeal Carcinoma, Mononucleosis, Esophageal Cancer, and Agranulocytosis.

His clinical research consists of co-authoring 105 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Mononucleosis.

Gender
Male

Locations

1/F Professorial Block, 102 Pokfulam Road, Hong Kong, HCW, Hong Kong Special Administrative Region
Other Locations
Room 406, Pok Fu Lam Road, Hong Kong, HCW, Hong Kong Special Administrative Region
Pokfulam Road, Hong Kong, HCW, Hong Kong Special Administrative Region

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Feasibility Study of Intraperitoneal Docetaxel Combined With Intravenous Cisplatin and Oral TS-ONE for Gastric Cancer Patients With Peritoneal Carcinomatosis
Feasibility Study of Intraperitoneal Docetaxel Combined With Intravenous Cisplatin and Oral TS-ONE for Gastric Cancer Patients With Peritoneal Carcinomatosis
Enrollment Status: Completed
Publish Date: May 04, 2018
Intervention Type: Drug
Study Phase: Phase 1

105 Total Publications

Oncogenic NFE2L2 mutations in plasma ctDNA and tumors are predictors and prognosticators of chemoradiation therapy in resectable esophageal squamous cell carcinoma.
Oncogenic NFE2L2 mutations in plasma ctDNA and tumors are predictors and prognosticators of chemoradiation therapy in resectable esophageal squamous cell carcinoma.
Journal: British journal of cancer
Published: November 04, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lam's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile